index,evidence,llm_statement,indra_statement,similarity_rating,llm_explanation,llm_subject,llm_relationship,llm_object,indra_subject,indra_relationship,indra_object,subject_match,relationship_match,object_match,subject_namespace_match,object_namespace_match,match_score,match_type
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity leads to the phosphorylation of HSF1 at Serine 326. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.","act(p(HGNC:MTOR), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MTOR), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.","act(p(HGNC:DYRK2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:DYRK2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Threonine 142. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1, but the phosphorylation sites are different (Thr142 vs Thr527). This difference in phosphorylation sites can significantly alter the biological function and impact of the interaction.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification type and site differ: the LLM statement describes phosphorylation at Threonine 142, while the INDRA statement describes phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification type and site differ: the LLM statement describes phosphorylation at Threonine 142, while the INDRA statement describes phosphorylation at Serine 230.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Serine 230. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT1 increases the phosphorylation of HSF1. However, the phosphorylation site differs between the two statements (Ser230 vs Ser326), which can significantly affect the biological outcome.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) differ in the type of residue and the position, with the LLM statement indicating phosphorylation at Serine 230 and the INDRA statement indicating phosphorylation at Threonine 527.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) differ in the type of amino acid being modified (Serine vs Threonine) and the position of the modification (230 vs 142).","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Good,"Both statements describe the same biological event where AKT1 kinase activity directly increases the phosphorylation of HSF1 at Threonine 527. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a similar biological event where AKT1 increases the phosphorylation of HSF1. However, the phosphorylation sites are different (Thr 527 in the LLM statement vs Thr 142 in the INDRA statement), which could potentially lead to different biological outcomes.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification details differ: the LLM statement describes a phosphorylation at Threonine 527, while the INDRA statement describes a phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1, but the post-translational modifications (pmod) are different. In the LLM statement, HSF1 is phosphorylated at Threonine 527, while in the INDRA statement, it is phosphorylated at Serine 230.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
4,"Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases act(p(HGNC:HSF1))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,"AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).","act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases act(p(HGNC:HSF1))",,,,"act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT1 kinase activity directly increases the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where a protein (AKT) increases the phosphorylation of another protein (HSF1). However, the LLM statement refers to AKT1, while the INDRA statement refers to AKT2, which are different isoforms of the AKT protein. Therefore, the similarity is rated as medium.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity directly increases the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT increases the phosphorylation of HSF1 at Serine 326. However, the LLM statement refers to AKT2 while the INDRA statement refers to AKT1, which are different isoforms of the AKT protein.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
5,"AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).","act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
5,mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.,"act(p(HGNC:MTOR), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MTOR), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
6,"Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress.",p(HGNC:AKT1) directlyIncreases complex(p(HGNC:HSF1)),,,,p(HGNC:AKT1),directlyIncreases,complex(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
6,AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization.,p(HGNC:AKT2) directlyIncreases complex(p(HGNC:HSF1)),,,,p(HGNC:AKT2),directlyIncreases,complex(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
6,AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization.,p(HGNC:AKT3) directlyIncreases complex(p(HGNC:HSF1)),,,,p(HGNC:AKT3),directlyIncreases,complex(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding.","p(HGNC:AKT1) directlyIncreases act(p(HGNC:HSF1), ma(GO:DNA binding))",,,,p(HGNC:AKT1),directlyIncreases,"act(p(HGNC:HSF1), ma(GO:DNA binding))",,,,False,False,False,False,False,0.0,LLM Only
6,Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms.,p(HGNC:AKT1) directlyIncreases r(HGNC:HSPA1A),,,,p(HGNC:AKT1),directlyIncreases,r(HGNC:HSPA1A),,,,False,False,False,False,False,0.0,LLM Only
6,Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms.,p(HGNC:AKT1) directlyIncreases r(FPLX:HSP90),,,,p(HGNC:AKT1),directlyIncreases,r(FPLX:HSP90),,,,False,False,False,False,False,0.0,LLM Only
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",p(HGNC:NOS2) increases a(CHEBI:3-nitrotyrosine),,,,p(HGNC:NOS2),increases,a(CHEBI:3-nitrotyrosine),,,,False,False,False,False,False,0.0,LLM Only
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",act(p(HGNC:NOS2)) increases act(a(CHEBI:NADPH)),,,,act(p(HGNC:NOS2)),increases,act(a(CHEBI:NADPH)),,,,False,False,False,False,False,0.0,LLM Only
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",act(p(HGNC:JAK2)) directlyIncreases bp(GO:catabolic process),,,,act(p(HGNC:JAK2)),directlyIncreases,bp(GO:catabolic process),,,,False,False,False,False,False,0.0,LLM Only
9,"The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).","complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,"complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(HGNC:ERCC5), p(FPLX:RPA))",,,,"complex(p(HGNC:ERCC5), p(FPLX:RPA))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1))",,,,"complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(HGNC:ERCC5), p(HGNC:XPA))",,,,"complex(p(HGNC:ERCC5), p(HGNC:XPA))",,,,,,False,False,False,False,False,0.0,LLM Only
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK1A), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different both in terms of the proteins involved and the relationships described. The first statement involves DYRK1A increasing the phosphorylation of SIRT1, while the second statement involves SIRT1 decreasing the acetylation of TP53.","act(p(HGNC:DYRK1A), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.2486111111111111,Best Match
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK3), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different in their biological meaning. The first statement describes DYRK3 increasing the phosphorylation of SIRT1, while the second statement describes SIRT1 decreasing the acetylation of TP53. The subjects, objects, and relationships are all different.","act(p(HGNC:DYRK3), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.2486111111111111,Best Match
11,"AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.","act(p(FPLX:AMPK), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 344))",,,,"act(p(FPLX:AMPK), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 344))",,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","act(p(HGNC:SETD7), ma(GO:""methyltransferase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 233))",,,,"act(p(HGNC:SETD7), ma(GO:""methyltransferase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Me, Lys, 233))",,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","act(p(HGNC:SETD7), ma(GO:""methyltransferase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 235))",,,,"act(p(HGNC:SETD7), ma(GO:""methyltransferase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Me, Lys, 235))",,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","act(p(HGNC:SETD7), ma(GO:""methyltransferase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 236))",,,,"act(p(HGNC:SETD7), ma(GO:""methyltransferase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Me, Lys, 236))",,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","act(p(HGNC:SETD7), ma(GO:""methyltransferase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 238))",,,,"act(p(HGNC:SETD7), ma(GO:""methyltransferase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Me, Lys, 238))",,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","act(p(HGNC:SUMO1), ma(GO:""SUMO transferase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,"act(p(HGNC:SUMO1), ma(GO:""SUMO transferase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","act(p(HGNC:SENP1), ma(GO:""protein desumoylation"")) directlyDecreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,"act(p(HGNC:SENP1), ma(GO:""protein desumoylation""))",directlyDecreases,"p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,False,False,False,False,False,0.0,LLM Only
11,"Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1α transcriptional activity.","p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 387))",,,,p(HGNC:GAPDH),directlyIncreases,"p(HGNC:SIRT1, pmod(NO, Cys, 387))",,,,False,False,False,False,False,0.0,LLM Only
11,"Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1α transcriptional activity.","p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 390))",,,,p(HGNC:GAPDH),directlyIncreases,"p(HGNC:SIRT1, pmod(NO, Cys, 390))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT1) localizes bp(GO:nucleus),,,,p(HGNC:SIRT1) localizes bp(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT6) localizes bp(GO:nucleus),,,,p(HGNC:SIRT6) localizes bp(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT7) localizes bp(GO:nucleus),,,,p(HGNC:SIRT7) localizes bp(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT2) localizes bp(GO:cytoplasm),,,,p(HGNC:SIRT2) localizes bp(GO:cytoplasm),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT3) localizes bp(GO:mitochondrion),,,,p(HGNC:SIRT3) localizes bp(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT4) localizes bp(GO:mitochondrion),,,,p(HGNC:SIRT4) localizes bp(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT5) localizes bp(GO:mitochondrion),,,,p(HGNC:SIRT5) localizes bp(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT1), ma(GO:""deacetylase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT1), ma(GO:""deacetylase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT5), ma(GO:""deacetylase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT5), ma(GO:""deacetylase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT4), ma(GO:""ADP-ribosyltransferase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT4), ma(GO:""ADP-ribosyltransferase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT6), ma(GO:""ADP-ribosyltransferase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT6), ma(GO:""ADP-ribosyltransferase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT2), ma(GO:""deacetylase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT2), ma(GO:""deacetylase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT2), ma(GO:""ADP-ribosyltransferase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT2), ma(GO:""ADP-ribosyltransferase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT3), ma(GO:""deacetylase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT3), ma(GO:""deacetylase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT3), ma(GO:""ADP-ribosyltransferase activity"")) increases a(CHEBI:ADP)",,,,"act(p(HGNC:SIRT3), ma(GO:""ADP-ribosyltransferase activity""))",increases,a(CHEBI:ADP),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 has been implicated in signaling pathways underlying various diseases, including: diabetes, cardiovascular disease, neurodegeneration, cancer, aging, and obesity.","act(p(HGNC:SIRT1), ma(GO:nucleic acid binding transcription factor activity)) depends a(CHEBI:NAD(+))",,,,"act(p(HGNC:SIRT1), ma(GO:nucleic acid binding transcription factor activity)) depends a(CHEBI:NAD(+))",,,,,,False,False,False,False,False,0.0,LLM Only
13,"...deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:MAP3K7) directlyDecreases bp(GO:""apoptotic process"")",,,,p(HGNC:MAP3K7),directlyDecreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"...deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:IKBKG) directlyDecreases bp(GO:""apoptotic process"")",,,,p(HGNC:IKBKG),directlyDecreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)...",p(HGNC:TNF) directlyIncreases p(FPLX:NFkappaB),,,,p(HGNC:TNF),directlyIncreases,p(FPLX:NFkappaB),,,,False,False,False,False,False,0.0,LLM Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)...",p(HGNC:TNF) directlyIncreases p(FPLX:JNK),,,,p(HGNC:TNF),directlyIncreases,p(FPLX:JNK),,,,False,False,False,False,False,0.0,LLM Only
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis.",p(HGNC:TNF) association act(p(FPLX:NFkappaB)),,,,p(HGNC:TNF),association,act(p(FPLX:NFkappaB)),,,,False,False,False,False,False,0.0,LLM Only
15,A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation,p(HGNC:TNFAIP3) directlyDecreases p(HGNC:MAP3K5),,,,p(HGNC:TNFAIP3),directlyDecreases,p(HGNC:MAP3K5),,,,False,False,False,False,False,0.0,LLM Only
15,ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated,p(HGNC:MAP3K5) increases p(FPLX:JNK),,,,p(HGNC:MAP3K5),increases,p(FPLX:JNK),,,,False,False,False,False,False,0.0,LLM Only
15,"We here showed that TNF affects the interaction between A20 and ASK1, which could explain the ASK1-dependent phosphorylation of JNK at specific periods after TNF administration","p(HGNC:TNF) regulates complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,p(HGNC:TNF),regulates,"complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,False,False,False,False,False,0.0,LLM Only
16,"Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.","complex(p(FPLX:C1), p(FPLX:C1q), p(HGNC:C1R)) directlyIncreases act(p(HGNC:C4A), ma(GO:""cleaving activity""))",,,,"complex(p(FPLX:C1), p(FPLX:C1q), p(HGNC:C1R))",directlyIncreases,"act(p(HGNC:C4A), ma(GO:""cleaving activity""))",,,,False,False,False,False,False,0.0,LLM Only
16,"The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.","complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C3), ma(GO:""cleaving activity""))",,,,"complex(p(HGNC:C4B), p(HGNC:C2))",directlyIncreases,"act(p(HGNC:C3), ma(GO:""cleaving activity""))",,,,False,False,False,False,False,0.0,LLM Only
17,"For example, in the fluid phase, factor H can bind to C3b, preventing the formation of the C3 convertase.",p(HGNC:CFH) directlyDecreases act(p(HGNC:C3)),,,,p(HGNC:CFH),directlyDecreases,act(p(HGNC:C3)),,,,False,False,False,False,False,0.0,LLM Only
17,"Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.","complex(p(HGNC:CFH), p(HGNC:C3)) => act(p(HGNC:CFI))",,,,"complex(p(HGNC:CFH), p(HGNC:C3)) => act(p(HGNC:CFI))",,,,,,False,False,False,False,False,0.0,LLM Only
18,Li and coworkers demonstrated that partial sciatic nerve ligation activated complement.,a(GO:'complement activation') increases p(HGNC:C3),,,,a(GO:'complement activation'),increases,p(HGNC:C3),,,,False,False,False,False,False,0.0,LLM Only
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) regulates p(HGNC:TLR4),p(HGNC:11850 ! TLR4) increases p(HGNC:11850 ! TLR4),Bad,"The two statements are not similar. The LLM statement suggests that SLAMF1 regulates TLR4, while the INDRA statement suggests that TLR4 increases itself, which is a different biological concept.",p(HGNC:SLAMF1),regulates,p(HGNC:TLR4),p(HGNC:TLR4),increases,p(HGNC:TLR4),False,False,True,True,True,0.47500000000000003,Best Match
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) regulates p(HGNC:TLR4),p(HGNC:11850 ! TLR4) increases p(HGNC:5434 ! IFNB1),Bad,"The two statements are quite different. The first statement suggests that SLAMF1 regulates TLR4, while the second statement suggests that TLR4 increases IFNB1. There is no overlap in the relationships or the entities involved.",p(HGNC:SLAMF1),regulates,p(HGNC:TLR4),p(HGNC:TLR4),increases,p(HGNC:IFNB1),False,False,False,True,True,0.35000000000000003,Secondary Match
19,We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,,,False,False,False,False,False,0.0,LLM Only
20,This results in an immediate activation of nuclear factor kappaB (NF-kappaB) and production of proinflammatory cytokines.,p(HGNC:TLR4) directlyIncreases p(FPLX:NFkappaB),,,,p(HGNC:TLR4),directlyIncreases,p(FPLX:NFkappaB),,,,False,False,False,False,False,0.0,LLM Only
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",,p(HGNC:392 ! AKT2) increases p(HGNC:5224 ! HSF1),INDRA Only,,,,,p(HGNC:AKT2),increases,p(HGNC:HSF1),False,False,False,False,False,0.0,INDRA Only
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",,"a(TEXT:""Fig. 1A-D"") increases p(HGNC:5224 ! HSF1)",INDRA Only,,,,,"a(TEXT:""Fig. 1A-D"")",increases,p(HGNC:HSF1),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:392 ! AKT2) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT2),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:392 ! AKT2) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT2),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:391 ! AKT1) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT1),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:391 ! AKT1) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT1),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:393 ! AKT3) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT3),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:393 ! AKT3) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT3),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",,p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),INDRA Only,,,,,p(HGNC:TNF),increases,p(FPLX:NFkappaB),False,False,False,False,False,0.0,INDRA Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",,p(HGNC:11892 ! TNF) increases p(FPLX:JNK ! JNK),INDRA Only,,,,,p(HGNC:TNF),increases,p(FPLX:JNK),False,False,False,False,False,0.0,INDRA Only
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",,"p(HGNC:11892 ! TNF) increases bp(GO:""GO:0007165"" ! ""signal transduction"")",INDRA Only,,,,,p(HGNC:TNF),increases,"bp(GO:""GO:0007165"" ! ""signal transduction"")",False,False,False,False,False,0.0,INDRA Only
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",,p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),INDRA Only,,,,,p(HGNC:TNF),increases,p(FPLX:NFkappaB),False,False,False,False,False,0.0,INDRA Only
15,ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated.,,"p(HGNC:6857 ! MAP3K5) directlyIncreases p(FPLX:JNK ! JNK, pmod(go:0006468 ! ""protein phosphorylation""))",INDRA Only,,,,,p(HGNC:MAP3K5),directlyIncreases,"p(FPLX:JNK, pmod(go:0006468 ! ""protein phosphorylation""))",False,False,False,False,False,0.0,INDRA Only
15,A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation.,,p(FPLX:JNK ! JNK) increases p(HGNC:11892 ! TNF),INDRA Only,,,,,p(FPLX:JNK),increases,p(HGNC:TNF),False,False,False,False,False,0.0,INDRA Only
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",,p(HGNC:11850 ! TLR4) increases p(FPLX:IFNB ! IFNB),INDRA Only,,,,,p(HGNC:TLR4),increases,p(FPLX:IFNB),False,False,False,False,False,0.0,INDRA Only
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,,"p(HGNC:10903 ! SLAMF1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",INDRA Only,,,,,p(HGNC:SLAMF1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",False,False,False,False,False,0.0,INDRA Only
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,,"p(HGNC:20568 ! TRAM1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",INDRA Only,,,,,p(HGNC:TRAM1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",False,False,False,False,False,0.0,INDRA Only
